Belvedere Trading »

Vir Biotechnology shares owned by Belvedere Trading

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-06-30 $461k 19k 24.53
2023-03-31 $271k 12k 23.27

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
D. E. Shaw & Co
Charles Schwab Investment Management
Bank of New York Mellon
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Principal Financial Group
Dimensional Fund Advisors
Barclays
Millennium Management

View all funds holding Vir Biotechnology